Original language | English |
---|---|
Pages (from-to) | 15-16 |
Number of pages | 2 |
Journal | Journal of Orthopaedic Research |
Volume | 34 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2016 |
Reply to "does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?" by Wei et al.
Steven A. Olson, Bridgette D. Furman, Virginia B. Kraus, Janet L. Huebner, Farshid Guilak
- Department of Orthopedic Surgery
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Center for the Investigation of Membrane Excitability Diseases
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Division of Basic Research
- Center of Regenerative Medicine
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
Research output: Contribution to journal › Letter › peer-review
1
Scopus
citations